Article: No home run yet with cystic fibrosis therapies.(News)

MONTREAL -- A variety of new therapeutic approaches are being utilized to control airway inflammation in cystic fibrosis, but the optimal form of therapy remains to be defined, Dr. Felix Ratjen said at the Seventh International Congress on Pediatric Pulmonology.

Airway inflammation is present in most cystic fibrosis (CF) patients, but it is not yet known whether this is specific to CF or related to a defect of mucus airway clearance. Therefore, two different therapeutic approaches have emerged--one that directly targets inflammation and a second that targets the underlying defect.

In either case, a better understanding of the factors regulating ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!